Their bioactivity involves modulation of hypoxia inducible factor-1(HIF-1) and mitogen-activated protein kinase (MAPK) signaling pathways, influencing tumor cell proliferation, transendothelial neutrophil migration, invasive capacity, and chemoresistance (25). The gene discussed is WNK2; the disease is neoplasm.